Chad Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Combination Therapy for the Treatment of Diffuse Midline Gliomas
Conditions:   Diffuse Intrinsic Pontine Glioma;   Diffuse Midline Glioma, H3 K27M-Mutant;   Recurrent Diffuse Intrinsic Pontine Glioma;   Recurrent Diffuse Midline Glioma, H3 K27M-Mutant;   Recurrent WHO Grade III Glioma;   WHO Grade III Glioma Interventions:   Drug: ONC201;   Radiation: Radiation Therapy;   Drug: Panobinostat;   Drug: Paxalisib Sponsors:   University of California, San Francisco;   The Chad-Tough Defeat DIPG Foundation;   Mithil Prasad Foundation;   Storm the Heavens Fund Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials